COMMUNIQUÉS West-GlobeNewswire

Loop Industries Reports Fourth Quarter and Fiscal 2018 Consolidated Results
15/05/2018
Company used $2.2 million for the quarter and $6.4 million for the fiscal year of cash in operating activities to significantly advance its technology and fund its growth strategy Raised $8.6 million through a private [...]
Sirona Biochem Receives TSX Venture Exchange Approval on Warrant Extension
15/05/2018
VANCOUVER, British Columbia, May 14, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM ) (FRANKFURT: ZSB ), announces an extension to the term of 2,073,750 common share purchase warrants (the “Warrants”) [...]
BIONOVELUS' FIRST QUARTER REPORTS
15/05/2018
FOR IMMEDIATE RELEASE — Phoenix, May 14, 2018 (GLOBE NEWSWIRE) -- / BioNovelus (OTC Pink: ONOV) has published today its first quarter of 2018 financial statements and report. This information is attached to this Press [...]
MediSix Therapeutics Launches with USD$20M Series A Financing
15/05/2018
Company will develop novel CAR-T immune engineering platform targeting T-cell malignancies SINGAPORE, May 14, 2018 (GLOBE NEWSWIRE) -- MediSix Therapeutics Pte. Ltd., a development-stage cell therapy company creating [...]
Arcturus Therapeutics Files Form 20-F
14/05/2018
SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today announced the filing of the Company’s Annual Report on Form 20-F for the fiscal year ended [...]
Mustang Bio Reports First Quarter 2018 Financial Results
14/05/2018
NEW YORK, May 14, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
ADMA Biologics Reports First Quarter 2018 Financial Results
14/05/2018
Key Manufacturing Milestones Achieved During First Quarter RAMSEY, N.J. and BOCA RATON, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA ) (“ADMA” or the “Company”), today announced its [...]
EDAP TMS SA : EDAP Reports 2018 First Quarter Results
14/05/2018
2018 Q1 total revenue records a 6% increase year-over-year Focal One Final Additional Information submitted to FDA early May EDAP to attend American Urological Association congress in San Francisco, May 18-21, 2018 LYON [...]
Invuity Announces Results of New PhotonBlade® Studies at 2018 Heart Rhythm Society Conference
14/05/2018
Researchers identify critical factors to minimize damage when using electrocautery near insulated pacing leads and demonstrate a reduced risk of damaging lead insulation with the use of PhotonBlade SAN FRANCISCO, May 14 [...]
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of XEN1101 and XEN901 Presentations at 14th Eilat Conference
14/05/2018
BURNABY, British Columbia, May 14, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today announced that it will provide a corporate update and overview of [...]
IMV Inc. (Formerly Immunovaccine Inc.) Announces Q1 2018 Financial Results
14/05/2018
HALIFAX, Nova Scotia, May 14, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX: IMV ) (OTCQX:IMMVD), a clinical stage immuno-oncology corporation, today released its financial and operational results for the first quarter ended [...]
ERYTECH Reports First Quarter 2018 Financial Results and Provides Business Update
14/05/2018
Conference call and webcast scheduled for Tuesday, May 15th at 2:30 pm CET/8:30 am EDT Finalized Phase 3 trial design for eryaspase in second line pancreatic cancer; on track for expected start of patient enrollment in [...]
Molecular Templates, Inc. Reports First Quarter 2018 Financial Results
14/05/2018
MT-3724 Phase Ib Ongoing; Combination Studies Expected to Start in 2H18 AUSTIN, Texas, May 14, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM ) (“Molecular”), a clinical-stage oncology company focused [...]
HealthEquity Sets Date to Announce First Quarter Results Fiscal Year 2019
14/05/2018
Attend Investor Conferences DRAPER, Utah, May 14, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the largest HSA non-bank custodian, today announced that it plans to [...]
Avinger Announces First Quarter 2018 Financial Results
14/05/2018
REDWOOD CITY, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the first quarter ended [...]
Medigus Broadens Availability of MUSE™ Through Distribution Agreement with MELEKIRMAK in Turkey, Azerbaijan and Georgia
14/05/2018
OMER, Israel, May 14, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS ) (TASE: MDGS ), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, [...]
Cyclacel Pharmaceuticals Reports First Quarter 2018 Financial Results
14/05/2018
Conference Call Scheduled May 14, 2018 at 4:30 p.m. EDT BERKELEY HEIGHTS, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company"), a [...]
ImmuCell Announces Financial Results for First Quarter of 2018
14/05/2018
PORTLAND, Maine, May 14, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC ) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update
14/05/2018
Conference Call to be Held at 4:30 p.m. ET (1:30 p.m. PT) RANCHO CORDOVA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care [...]

Pages